KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Shareholder's Equity Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.78%
Dec 31, 2025 33.23%
Sep 30, 2025 38.09%
Jun 30, 2025 45.35%
Mar 31, 2025 89.23%
Dec 31, 2024 -4.27%
Sep 30, 2024 -2.88%
Jun 30, 2024 -10.44%
Mar 31, 2024 -18.67%
Dec 31, 2023 -12.83%
Sep 30, 2023 -11.27%
Jun 30, 2023 -13.99%
Mar 31, 2023 -17.39%
Dec 31, 2022 -27.67%
Sep 30, 2022 -30.60%
Jun 30, 2022 -39.26%
Mar 31, 2022 -56.11%
Dec 31, 2021 -18.77%
Sep 30, 2021 -16.96%
Jun 30, 2021 -17.91%
Mar 31, 2021 -15.77%
Dec 31, 2020 -28.03%
Sep 30, 2020 -30.20%
Jun 30, 2020 374.14%
Mar 31, 2020 204.39%
Dec 31, 2019 -31.33%
Sep 30, 2019 -29.19%
Jun 30, 2019 237.01%
Mar 31, 2019 351.10%
Dec 31, 2018 -23.65%
Sep 30, 2018 -19.94%
Jun 30, 2018 -18.44%
Mar 31, 2018 -16.16%
Dec 31, 2017 -0.70%
Sep 30, 2017 8.37%
Jun 30, 2017 -83.99%
Mar 31, 2017 -26.33%
Dec 31, 2016 10.58%
Sep 30, 2016 12.30%
Jun 30, 2016 -76.08%
Mar 31, 2016 -81.77%
Dec 31, 2015 13.79%
Sep 30, 2015 12.01%
Dec 31, 2014 10.65%
Sep 30, 2014 2.45%
Jun 30, 2014 -1.63%
Mar 31, 2014 -3.09%
Dec 31, 2013 -2.64%
Sep 30, 2013 -3.36%
Jun 30, 2013 -3.85%
Mar 31, 2013 -4.44%
Dec 31, 2012 -5.61%
Sep 30, 2012 -4.51%